Thermosome Reports Promising Phase I Results for THE001 and Regional Hyperthermia in Soft Tissue Sarcoma Patients

Thermosome GmbH, a clinical-stage drug development company focused on targeted tumor therapies, today announced new, encouraging data from its ongoing Ph...

June 24, 2025 | Tuesday | News
Perceptive Discovery Launches FIBRE Consortium with Pfizer, Lantheus, and Lumina to Advance Imaging Biomarkers in Fibrotic Diseases

Perceptive Discovery, a global leader in molecular and functional imaging research, today announced the launch of the FIBRE (Fibrosis Imaging Biomarker R...

June 23, 2025 | Monday | News
Yale School of Medicine Launches Biomedical Imaging Institute to Drive Innovation in Health and Disease Research

Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that will unite leading experts in ...

June 23, 2025 | Monday | News
Harbour BioMed and Otsuka Enter $670M+ Global Agreement Across Asia, US, and Europe to Advance Bispecific T-Cell Engager for Autoimmune Diseases

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology ...

June 23, 2025 | Monday | News
PharmaJet and Immuno Cure Partner to Advance Needle-Free HIV Therapeutic DNA Vaccine with Tropis® ID System

Agreement builds on PharmaJet’s strategy to be the best-in-class delivery system for novel DNA- and RNA-based vaccines and immunotherapies usin...

June 20, 2025 | Friday | News
Neurona Therapeutics Doses First Patient in Bilateral MTLE Trial of Regenerative Cell Therapy NRTX-1001

First patient received bilateral administration of NRTX-1001; no significant surgical complications or adverse events reported to date - - Trial funded...

June 19, 2025 | Thursday | News
University of Oxford and ReciBioPharm Expand Collaboration to Manufacture Malaria Vaccine Candidates

  Expands the collaboration to manufacture two malaria vaccine candidates (R78C and RH5.1) for Phase 1/2 clinical trials. Delivers the sixth m...

June 17, 2025 | Tuesday | News
Innovent Doses First Patient in Phase 3 Trial of Mazdutide for Obstructive Sleep Apnea and Obesity in China

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

June 16, 2025 | Monday | News
Chiesi Group and Key2Brain Expand Collaboration to Advance BBB-Crossing Therapies for Ultra-Rare Lysosomal Storage Disorders

Collaboration will leverage Key2Brain’s technology to develop blood-brain barrier-crossing enzyme replacement therapies for lysosomal storage disor...

June 12, 2025 | Thursday | News
HepaRegeniX Doses First Patient in Phase Ib Trial of HRX-215 for Liver Regeneration After Colorectal Cancer Surgery

HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, announced that...

June 11, 2025 | Wednesday | News
XL-protein and Grifols Partner to Develop Novel Long-Acting Biopharmaceutical Using PASylation® Technology

XL-protein GmbH, a pioneer in the area of biopolymers for pharmacokinetic optimization, announced  that it has entered into a worldwide License, Dev...

June 11, 2025 | Wednesday | News
SynaptixBio Advances First Clinical Candidate for Rare H-ABC Disease With Promising Antisense Oligonucleotide Therapy

SynaptixBio, the only company licensed to commercialise a treatment for a rare, deadly disease, says the drug could halt disease progression and even rever...

June 11, 2025 | Wednesday | News
IonQ, AstraZeneca, AWS, and NVIDIA Achieve 20x Speedup in Quantum-Accelerated Drug Development Workflow

Largest demonstration of its kind combines leading hardware, platforms, and techniques to achieve 20 times speedup over previous demonstrations Ecosys...

June 10, 2025 | Tuesday | News
OBI Pharma and TegMine Therapeutics Enter ADC Collaboration to Target Cancer-Specific Glycans

OBI Pharma, Inc. (OBI), a clinical-stage global oncology company specialized in the development of novel cancer therapies such as antibody-drug conjugate...

June 10, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close